MAP Biosurgery Product (e.g., TT101)
Soft tissue reconstruction (Dermal and Abdominal Wall)
Pre-clinicalActive
Key Facts
Indication
Soft tissue reconstruction (Dermal and Abdominal Wall)
Phase
Pre-clinical
Status
Active
Company
About Tempo Therapeutics
Tempo Therapeutics is a private, preclinical-stage biotech company pioneering a novel tissue engineering platform called MAP (Microporous Annealed Particle). This technology creates synthetic, immune-modulating scaffolds that promote regeneration and avoid scarring, with initial applications in biosurgery for dermal and abdominal wall reconstructions. The company is led by a scientifically robust team, including founders from academia, and is exploring broader applications in drug delivery and cell engraftment. Tempo is pre-revenue and actively seeking strategic partnerships to advance its pipeline and expand into new therapeutic areas.
View full company profile